Shareable Research Card

OEC - Orion S.A. Research And Development Expense

This metric view shows OEC - Orion S.A. research and development expense history from SEC company facts.

Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.

Context
Latest reported period: Q3 2018
Latest reported value
$4,872,000

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.

Return Loop

Why revisit this metric view

This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.

Latest source-backed update
Latest period end 30 Sep 2018
Why come back
Return after the next filing to verify whether this metric changed and how it compares with the ranking page.
  • Current latest reported period: Q3 2018.
  • Latest reported value on this page: $4,872,000.
  • Save this filer if you want to compare the next reported value with this history.

Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.

Latest update

Latest update for Research And Development Expense

New fact period available

Latest reported research and development expense: $4,872,000. Open the source-backed page to compare this metric with the newest filing-backed context.

Update date

30 Sep 2018

Page type

Metric history

Latest period

Q3 2018

SEC-backed company facts were refreshed from filings filed on 05 Aug 2026.

Benchmark Context

How Research And Development Expense compares with peers

Orion S.A. sits in the bottom quarter of the current research and development expense sample.

Compared with

Compared with 120 companies reporting research and development expense in USD. This keeps the comparison on the same metric and unit family.

Why this is notable

This is about 0.1x the current sample midpoint. Research And Development Expense is up about 4.7% versus the comparable prior period.

  • Visible rows currently span reported period ends from 31 Dec 2017 to 31 Dec 2025.
  • Nearby companies in this sample: Mobilicom Ltd and Brenmiller Energy Ltd..
  • Current sample position: rank #114 of 120 comparable companies.
  • Peer rows use the latest valid value per company for this exact metric and compatible units.

Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Financial Metric Page

Orion S.A.: Research And Development Expense

Latest period: Q3 2018. Period end: 30 Sep 2018. Units: USD and EUR. Frequency: quarterly and annual.

Research And Development Expense is reported in company XBRL facts filed with the SEC.

What this metric tells you

  • Shows reported research and development expense over 31 Dec 2016 - 30 Sep 2018.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 6 SEC fact rows for this metric and issuer.

How to read this chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Compare This Metric Across Companies

Compare latest available Research And Development Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.

Orion S.A. appears at rank #114 in the latest comparison sample.

Rank Company Latest value Report period Next step
1 ASTRAZENECA PLC (azn) $14,232,000,000 Year - 31 Dec 2025 Open ASTRAZENECA PLC Research And Development Expense
2 NOVARTIS AG (nvs) $11,200,000,000 Year - 31 Dec 2025 Open NOVARTIS AG Research And Development Expense
3 TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (tsm) $6,227,000,000 Year - 31 Dec 2024 Open TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD Research And Development Expense
4 GENMAB A/S (gmab) $1,606,000,000 Year - 31 Dec 2025 Open GENMAB A/S Research And Development Expense
5 ARGENX SE (argx) $1,364,132,000 Year - 31 Dec 2025 Open ARGENX SE Research And Development Expense
6 Shell plc (shel) $1,170,000,000 Year - 31 Dec 2025 Open Shell plc Research And Development Expense

Metric Details

Metric identity Names, identifiers, and filing context for this profile. 1 identity field
Taxonomy
ifrs-full
Metric coverage 3 source fields
Units tracked
USD and EUR
History range
31 Dec 2016 - 30 Sep 2018
Freshness: From parsed SEC XBRL facts on this page
Facts on this page
6
Source: SEC company facts API
Source evidence Original filing metadata and source links for verification. 1 source field
SEC metric endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Research And Development Expense, Quarterly (USD)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (EUR)
Research And Development Expense, YoY Annual Change (%)

Orion S.A. Quarterly Research And Development Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2018 $4,872,000 +$217,000 +4.7% 01 Jul 2018 30 Sep 2018 6-K 01 Nov 2018 2018 Q3
Q2 2018 $4,644,000 +$188,000 +4.2% 01 Apr 2018 30 Jun 2018 6-K 02 Aug 2018 2018 Q2
Q3 2017 $4,655,000 01 Jul 2017 30 Sep 2017 6-K 01 Nov 2018 2018 Q3
Q2 2017 $4,456,000 01 Apr 2017 30 Jun 2017 6-K 02 Aug 2018 2018 Q2

Orion S.A. Annual Research And Development Expense (EUR)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2017 €16,074,000 +€1,544,000 +11% 01 Jan 2017 31 Dec 2017 20-F 23 Feb 2018 2017 FY
2016 €14,530,000 01 Jan 2016 31 Dec 2016 20-F 23 Feb 2018 2017 FY
* marks a reported value that did not pass the local value check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .